Pharmacokinetics and neurotropic effects of cyclo-L-prolylglycine and its modified analogues
The review presents the results of studies on the pharmacokinetics, metabolism, and bioavailability of new neurotropic dipeptide cyclo-Lprolilglycine (CPG) and their pharmacological activity. It was shown that the pharmacologically active metabolite of the nootropic drug noopept cyclo-Lprolilglycine...
Saved in:
Main Authors: | S. S. Boyko (Author), V. P. Zherdev (Author), K. N. Koliasnikova (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The relationship between the content of the potential psychopharmacological agent cyclo-L-prolylglycine in the brain of experimental animals and its antihypoxic effect
by: V. P. Zherdev, et al.
Published: (2020) -
Neuropeptide cyclo-L-prolylglycine counteracts scopolamine-induced long-term memory impairment in rats in the novel object recognition test
by: O. N. Vorontsova, et al.
Published: (2023) -
The influence of the pharmacokinetics and bioavailability of cyclo-L-propylglycine to the manifestation of its main pharmacological effects in experimental animals
by: S. S. Boyko, et al.
Published: (2021) -
The study of the permeability of the blood-brain barrier for new neurotropic peptide drugs
by: V. P. Zherdev, et al.
Published: (2019) -
Synthesis of cyclo-L-prolyl-glycine and study of its anti-parkinsonian activity
by: Ksenia Koliasnikova, et al.
Published: (2019)